Mrugank
☆    

India,
2012-08-18 20:22
(4647 d 07:50 ago)

Posting: # 9079
Views: 4,983
 

 Deviation in Dosing as per Randomisation schedule [GxP / QC / QA]

Dear All,

In double blind, three treatment study design - what are the resolution steps if Dosing treatment of two subjects have been interchange during Period - 1 ? Should we consider those two subjects continue for remaining study - if still Period 2 and Period 3 are remain ?

Is there any effect of it on result of study data?

Regards,
Mrugank


Edit: Category changed. [Helmut]
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2012-08-20 01:47
(4646 d 02:25 ago)

@ Mrugank
Posting: # 9082
Views: 4,126
 

 Double blind – or not?

Dear Mrugank!

❝ In double blind, three treatment study design - what are the resolution steps if Dosing treatment of two subjects have been interchange during Period - 1 ?


If this is a double blind study – how do you know the randomization was screwed up? Did the PI open the emergency envelopes and if yes, why?

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
Mrugank
☆    

India,
2012-08-20 18:37
(4645 d 09:36 ago)

@ Helmut
Posting: # 9084
Views: 4,116
 

 Double blind – or not?

Dear Helmut,

Randomization schedule has not been opened by PI till yet. Matter is we have dosed to two subjects interchangeably.
e.g. Subject Number 02 has been administered a treatment of subject Number 03 and vice versa.
Weather is it acceptable in any way ? Should we consider this two subjects continue for remaining study by shifting of treatment of both subjects in all 3 period?

Regards,
Mrugank
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2012-08-20 18:52
(4645 d 09:20 ago)

@ Mrugank
Posting: # 9085
Views: 4,186
 

 Major protocol deviation

Dear Mrugank!

❝ Randomization schedule has not been opened by PI till yet. Matter is we have dosed to two subjects interchangeably.

❝ e.g. Subject Number 02 has been administered a treatment of subject Number 03 and vice versa.


Sorry, I misinterpreted your first post.

❝ Weather is it acceptable in any way ? Should we consider this two subjects continue for remaining study by shifting of treatment of both subjects in all 3 period?


It should be possible, but:
  • I would say that’s a major protocol deviation.
  • It casts a damning light on your procedures. How did you detect the error? Can you confirm that the other subjects were dosed correctly?
  • Be prepared for an inspection.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes
UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,670 registered users;
106 visitors (0 registered, 106 guests [including 7 identified bots]).
Forum time: 04:13 CEST (Europe/Vienna)

We should not speak so that it is possible
for the audience to understand us,
but so that it is impossible
for them to misunderstand us.    Quintilian

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5